8th Immunotherapy of Cancer Conference (ITOC8)

The 8th Immunotherapy of Cancer Conference (ITOC8) to be held virtually from October 08 - 09, 2021 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.

The Conference is only accessible to certified healthcare professionals, associated press, industry representatives and other stakeholders in the science, management and prevention of cancer.

ITOC8 is organised by the Vienna Medical Academy (VMA) / Wiener Medizinische Akademie (WMA) GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.

The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

Session Topics:
• Emerging Concepts / New Agents
• Tumor microenvironment and microbiome in Immunotherapy
• Vaccine Therapy
• Pro & Contra Session
• Precision Medicine Meets Immunotherapy (Immuno-Monitoring)
• “Lost in Translation”?
• Lifetime Achievement Award
• Cell Therapy in Solid Tumors
• Cell Therapy in Haematologic Diseases
• Combination Therapy
• Young Researchers Session
• Best Poster Awards